23andMe, Inc.

Industry

  • Laboratory Testing Services
  • Services
  • In Vitro Diagnostics
    • Saliva-based Testing
    • Molecular Diagnostics & Genetic Testing
  • Digital Health
    • Disease Management
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Lemonaid Health
  • VG Acquisition
See more in Biomedtracker

Latest on 23andMe, Inc.

HBW Insight

Size Of 23andMe Data Breach Jumps To Nearly 7M

 
• By Hannah Daniel

OTC genetic testing company 23andMe, Inc. says the number of customers affected in an October data breach is 6.9m, much higher than originally reported. The California firm initially reported to the

Medtech Insight

23andMe Data Breach Larger Than Previously Reported

 
• By Hannah Daniel

Genetic testing company 23andMe, Inc. said that 6.9 million customers were affected in its October data breach, a much higher number than originally reported. The company initially reported to the U

Medtech Insight

Leo Grady’s Jona Hopes To Repair Microbiome Testing’s Murky Reputation

 
• By Barnaby Pickering

Leo Grady, the former CEO of Paige AI – developers of the first AI-based histology software to be granted approval by the US Food and Drug Administration – has turned his attention to the gut health

Scrip

Kanaph CEO On Surviving The Biotech Funding 'Barley Hump'

 
• By Jung Won Shin

“We feel that the biotech industry is going through the toughest time now. Everyone knows this, we are having so much difficulty...many investors seem to have stopped investment in the sector,” say By